Read More

Florida’s $6B Cannabis Market Anticipates 400% Growth Following Court Decision Allowing Nov. Legalization Ballot

Following the pivotal decision by the Florida Supreme Court, senior analyst Pablo Zuanic of Zuanic & Associates released a comprehensive report outlining the potent

AYRWF

Read More

EXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain Drug

PainReform hits a 50% enrollment target in the Phase 3 trial for PRF-110 in bunionectomy. No serious adverse events were reported. Over 200 patients enrolled across 8 U.S. sites. CEO Ilan Hadar is optimistic about PRF-110's potential to revolutionize postoperative pain management.

PRFX